These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15211432)
1. Herbs and the kidney. Isnard Bagnis C; Deray G; Baumelou A; Le Quintrec M; Vanherweghem JL Am J Kidney Dis; 2004 Jul; 44(1):1-11. PubMed ID: 15211432 [TBL] [Abstract][Full Text] [Related]
2. Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Hong YT; Fu LS; Chung LH; Hung SC; Huang YT; Chi CS Pediatr Nephrol; 2006 Apr; 21(4):577-9. PubMed ID: 16520953 [TBL] [Abstract][Full Text] [Related]
3. Kidney injury from alternative medicines. Colson CR; De Broe ME Adv Chronic Kidney Dis; 2005 Jul; 12(3):261-75. PubMed ID: 16010641 [TBL] [Abstract][Full Text] [Related]
4. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Lee S; Lee T; Lee B; Choi H; Yang M; Ihm CG; Kim M Nephrology (Carlton); 2004 Jun; 9(3):126-9. PubMed ID: 15189173 [TBL] [Abstract][Full Text] [Related]
5. Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis. Yang SS; Chu P; Lin YF; Chen A; Lin SH Am J Kidney Dis; 2002 Mar; 39(3):E14. PubMed ID: 11877594 [TBL] [Abstract][Full Text] [Related]
6. [Studies on the renal toxicity caused by aristolochic acids (AAs) and Chinese herbs containing AAs]. Liang AH; Ding XS; Liu BY Zhongguo Zhong Yao Za Zhi; 2004 Jan; 29(1):10-4. PubMed ID: 15709371 [TBL] [Abstract][Full Text] [Related]
9. [The clinical and pathological manifestations of aristolochic acid nephropathy--the report of 58 cases]. Chen W; Chen Y; Li A Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1101-5. PubMed ID: 11766606 [TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity and Chinese Herbal Medicine. Yang B; Xie Y; Guo M; Rosner MH; Yang H; Ronco C Clin J Am Soc Nephrol; 2018 Oct; 13(10):1605-1611. PubMed ID: 29615394 [TBL] [Abstract][Full Text] [Related]
12. Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy. Kazama I; Matsubara M; Michimata M; Suzuki M; Hatano R; Sato H; Ito S Clin Exp Nephrol; 2004 Sep; 8(3):283-7. PubMed ID: 15480910 [TBL] [Abstract][Full Text] [Related]
13. Association of blood lead and mercury with estimated GFR in herbalists after the ban of herbs containing aristolochic acids in Taiwan. Lin HH; Chou SA; Yang HY; Hwang YH; Kuo CH; Kao TW; Lo TC; Chen PC Occup Environ Med; 2013 Aug; 70(8):545-51. PubMed ID: 23703822 [TBL] [Abstract][Full Text] [Related]
15. [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)]. Nortier J Nephrologie; 2002; 23(1):37-8. PubMed ID: 11908479 [No Abstract] [Full Text] [Related]
16. Clinical and pathological spectrums of aristolochic acid nephropathy. Chen D; Tang Z; Luo C; Chen H; Liu Z Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338 [TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of Herbal Products in Europe-A Review of an Underestimated Problem. Kiliś-Pstrusińska K; Wiela-Hojeńska A Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923686 [TBL] [Abstract][Full Text] [Related]
18. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. Cosyns JP Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362 [TBL] [Abstract][Full Text] [Related]